Natalizumab
|
那他珠單抗
|
189261-10-7
|
dBET6
|
|
1950634-92-0
|
Salsoline
|
沙索林
|
89-31-6
|
Tinostamustine hydrochloride
|
|
1793059-58-1
|
5-Chloroimidazol[1,2-a]pyrimidine
|
5-氯咪唑并[1,2-A]嘧啶
|
944896-82-6
|
S-Gboxin
|
|
2101317-21-7
|
SGC-GAK-1
|
|
2226517-76-4
|
GLX351322
|
|
835598-94-2
|
2-Azidoethyl 2-bromoisobutyrate
|
|
1120364-53-5
|
TVB-2640
|
|
1399177-37-7
|
Adrenocorticotropic Hormone, Human
|
絲拉克肽
|
12279-41-3
|
Asapiprant
|
|
932372-01-5
|
ACT-709478
|
|
1838651-58-3
|
(S)-B-973B
|
|
2244989-34-0
|
CT-1812
|
|
1802632-22-9
|
SRI-011381
|
|
1629138-41-5
|
MDK-8650
|
|
736048-65-0
|
Glaucocalyxin A
|
藍萼甲素
|
79498-31-0
|
A-381393
|
|
726174-00-1
|
BB-Cl-Amidine
|
|
1802637-39-3
|
Cinaciguat hydrochloride
|
|
646995-35-9
|
BLU-782
|
|
2141955-96-4
|
BRL-50481
|
|
433695-36-4
|
Aurora Kinase Inhibitor III
|
|
879127-16-9
|
AUT1
|
|
1311136-84-1
|
Palivizumab
|
帕利珠單抗
|
188039-54-5
|
Methuosis inducer 1
|
|
2240205-30-3
|
TAS6417
|
|
1661854-97-2
|
Gardiquimod TFA
|
|
1159840-61-5
|
IPSU
|
|
1373765-19-5
|
SSE15206
|
|
1370046-40-4
|
(S)-5-bromo-6-fluoro-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide
|
|
1643156-23-3
|
L-Valinamide, N,N-dimethyl-L-valyl-N-[(1S,2R)-4-(1,1-dimethylethoxy)-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-
|
N,N-二甲基-L-纈氨酰-N-[(1S,2R)-4-(1,1-二甲基乙氧基)-2-甲氧基-1-[(1S)-1-甲基丙基] -4氧代丁基] -N-甲基-L-纈氨酰胺
|
120205-53-0
|
PhTx-74 dihydrochloride
|
|
1227301-51-0
|
SBC-110736
|
|
1629166-02-4
|
Thiambutosine
|
硫安布新
|
500-89-0
|
PCI-29732
|
|
330786-25-9
|
Azeliragon dihydrochloride
|
|
1284150-65-7
|
CP-671305
|
|
445295-04-5
|
4-Quinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo-
|
|
939760-13-1
|
6-Methoxynicotinamide
|
|
7150-23-4
|
CA-5f
|
|
1370032-19-1
|
Baloxavir Impurity 4
|
巴洛沙韋雜質4
|
1985607-70-2
|
TFAP
|
|
1011244-68-0
|
DBCO-Acid
|
|
1353016-70-2
|
1777832-90-2
|
|
1777832-90-2
|
6-Bromo-1H-indole-3-ethanamine monohydrochloride
|
|
108061-77-4
|
NT-157
|
|
1384426-12-3
|
NSC-23026
|
|
6616-56-4
|
ML-030
|
|
1013750-77-0
|
L-765314
|
|
189349-50-6
|
Cruzain-IN-1
|
|
1199523-24-4
|
GS-441524 sodium
|
|
1355050-21-3
|
1-Benzyl-3-[3-(diethylamino)propoxy]-1H-indazole
|
1-芐基-3-(3-二乙基氨基丙氧基)-1氫-吲唑
|
47448-66-8
|
Romosozumab
|
|
909395-70-6
|
Z-Phe-Tyr(tBu)-diazomethylketone
|
|
114014-15-2
|
Bis-(4-methoxy-phenyl)-[2]pyridyl-methanol
|
|
67916-54-5
|
Angelicin
|
異補骨脂素
|
523-50-2
|
DBCO-acid
|
|
1207355-31-4
|
Echinocystic acid
|
刺囊酸
|
510-30-5
|
Roquinimex
|
羅喹美克
|
84088-42-6
|
Irosustat
|
|
288628-05-7
|
SJ000291942
|
|
425613-09-8
|
KHS101 hydrochloride
|
|
1784282-12-7
|
MK-8722
|
|
1394371-71-1
|
E3 ligase Ligand 6
|
|
1631137-51-3
|
Eprobemide
|
依普貝胺
|
87940-60-1
|
Ethylhexylglycerin
|
乙基己基甘油
|
70445-33-9
|
HS1371
|
|
2158197-70-5
|
Hyaluronidase (human recombinant)
|
重組人類透明質酸酶
|
37326-33-3
|
MOG (35-55)
|
髓鞘少突膠質細胞糖蛋白
|
149635-73-4
|
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-((5-(4-fluorophenyl)-1H-indazol-3-yl)amino)-4-methoxyphenyl)acrylamide
|
|
2093395-24-3
|
T-26c
|
|
869296-13-9
|
Mono-2-(Methacryloyloxy)ethyl succinate
|
琥珀酸單[2-[(2-甲基-丙烯?;?氧]乙基]酯
|
20882-04-6
|
ZK824859
|
|
2254001-81-3
|
ODM-203
|
|
1430723-35-5
|
Chlorcyclizine dihydrochloride
|
氯環(huán)嗪二鹽酸鹽
|
129-71-5
|
Pulchinenoside B
|
白頭翁皂苷B
|
135247-95-9
|
Mavacamten
|
瑪伐凱泰
|
1642288-47-8
|
AX-024 hydrochloride
|
|
1704801-24-0
|
1-(6-chloro-1,3-benzodioxol-5-yl)acetone
|
|
1097726-08-3
|
Interferon receptor agonist
|
|
2215120-36-6
|
Nicainoprol
|
尼卡普醇
|
76252-06-7
|
TP-3654
|
|
1361951-15-6
|
QX77
|
|
1798331-92-6
|
PF-06700841 tosylate
|
|
2140301-96-6
|
2-Chlorooxazole-4-carboxamide
|
2-氯惡唑-4-甲酰胺
|
1025468-33-0
|
LIT-927
|
|
2172879-52-4
|
DMU2105
|
|
1821143-79-6
|
AF64394
|
|
1637300-25-4
|
CK-869
|
|
388592-44-7
|
Exo1
|
|
75541-83-2
|
CAY 10465
|
|
688348-33-6
|
BMS-962212
|
|
1430114-34-3
|
Ixekizumab
|
伊西貝單抗
|
1143503-69-8
|
NH125
|
|
278603-08-0
|
3PO
|
|
18550-98-6
|
UT-155
|
|
2031161-35-8
|
Givinostat
|
|
497833-27-9
|
Trisodium UDP glucuronic acid
|
尿苷葡萄糖醛酸三鈉
|
1191996-10-7
|